Lakshmi Chandrasekaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lakshmi Chandrasekaran has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Malabi M. Venkatesan
Walter Reed Army Institute of Research, Department of Diarrheal Disease Research, Bacterial Disease Branch, Silver Spring, MD 20910, USA
2 shared publications - Akamol E. Suvarnapunya
Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
1 shared publication - Alan Fix
PATH, Seattle, USA
1 shared publication Amanda Lynen
Naval Medical Research Center, Silver Spring, Maryland, USA
1 shared publicationAmy Hoeper
Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
1 shared publication- Chad K. Porter
Translational and Clinical Research Department, Infectious Diseases Directorate, Navy Medicine Research and Development Command, Silver Spring, MD 20910, USA
1 shared publication
Latest Publications
- Open Access
- 28 October 2020
- Published by American Society for Microbiology in mSphere
- Vol. 5 (5)
Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G
Controlled human infection models (CHIMs) are invaluable tools utilized to understand the human response to infection, potentially leading to protective immune mechanisms and allowing efficacy testing of enteric countermeasures, including vaccines, antibiotics, and other products. The development of an improved Shigella CHIM for both Shigella sonnei and Shigella flexneri is consistent with international efforts, supported by international donors and the World Health Organization, focused on standardizing Shigella CHIMs and using them to accelerate Shigella vaccine development. The use of lyophilized Shigella challenge strains rather than plate-grown inoculum preparations is considered an important step forward in the standardization process. Furthermore, the results of studies such as this justify the development of lyophilized preparations for additional epidemiologically important S. flexneri serotypes, including S. flexneri 3a and S. flexneri 6.
- 28 October 2020
- Published by American Society for Microbiology in mSphere
- Vol. 5 (5)
Open AccessEstablishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G
Controlled human infection models (CHIMs) are invaluable tools utilized to understand the human response to infection, potentially leading to protective immune mechanisms and allowing efficacy testing of enteric countermeasures, including vaccines, antibiotics, and other products. The development of an improved Shigella CHIM for both Shigella sonnei and Shigella flexneri is consistent with international efforts, supported by international donors and the World Health Organization, focused on standardizing Shigella CHIMs and using them to accelerate Shigella vaccine development. The use of lyophilized Shigella challenge strains rather than plate-grown inoculum preparations is considered an important step forward in the standardization process. Furthermore, the results of studies such as this justify the development of lyophilized preparations for additional epidemiologically important S. flexneri serotypes, including S. flexneri 3a and S. flexneri 6.